Evidence map›Paper›PMID 29552683›Full record

ReviewNatural product reports2018

Diiron monooxygenases in natural product biosynthesis.

Anna J Komor, Andrew J Jasniewski, Lawrence Que, John D Lipscomb

Abstract readReview
In one paragraph

Review in Natural product reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Electronic and Structural Heterogeneity in the Diiron Center of Sulerythrin: Insights From Hybrid QM/MM Calculations.Chemphyschem : a European journal of chemical physics and physical chemistry · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Iron-Containing Ureases.Coordination chemistry reviews · 2021
    Article
  9. Enzymkatalysierte späte Modifizierungen: Besser spät als nie.Angewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2021
    Review
  10. Enzymatic Late-Stage Modifications: Better Late Than Never.Angewandte Chemie (International ed. in English) · 2021
    Review
  11. Biosynthesis of fosfomycin in pseudomonads reveals an unexpected enzymatic activity in the metallohydrolase superfamily.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  12. Review
  13. Structure and assembly of the diiron cofactor in the heme-oxygenase-like domain of theProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. An Unusual Route forJournal of bacteriology · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Anna J KomorDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, USA. larryque@umn.edu.ORCID 0000-0003-4806-4233
Andrew J JasniewskiDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, USA. larryque@umn.edu.ORCID 0000-0001-7614-0796
Lawrence QueDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, USA. larryque@umn.edu.ORCID 0000-0002-0989-2813
John D LipscombDepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA. lipsc001@umn.edu.ORCID 0000-0002-8158-5594
University of Minnesota · US

Funding

Synthetic Models and Spectroscopy of Nonheme Diiron EnzymesR01GM038767 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI QUE, LAWRENCE · 1987 to 2018
$5.8M
Chemistry-Biology Interface Training GrantT32GM008700 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI DISTEFANO, MARK D · 1999 to 2018
$4.0M
Methane Monoxygenase Structure and FunctionR01GM040466 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LIPSCOMB, JOHN D · 1988 to 2009
$3.0M
Intermediates in O2 Activation by Oxygenases at Non-heme Iron CentersR35GM118030 · NIGMS · UNIVERSITY OF MINNESOTA · PI LIPSCOMB, JOHN D · 2016 to 2020
$2.7M
Roles of protein structure and diiron cluster chemistry in oxygen activationR01GM100943 · NIGMS · UNIVERSITY OF MINNESOTA · PI LIPSCOMB, JOHN D · 2012 to 2015
$1.2M
NIGMS NIH HHS R01 GM038767NIGMS NIH HHS R01 GM040466NIGMS NIH HHS R01 GM100943NIGMS NIH HHS R35 GM118030NIGMS NIH HHS T32 GM008700
6 · The paper itself

Abstract

Covering: up to 2017 The participation of non-heme dinuclear iron cluster-containing monooxygenases in natural product biosynthetic pathways has been recognized only recently. At present, two families have been discovered. The archetypal member of the first family, CmlA, catalyzes β-hydroxylation of l-p-aminophenylalanine (l-PAPA) covalently linked to the nonribosomal peptide synthetase (NRPS) CmlP, thereby effecting the first step in the biosynthesis of chloramphenicol by Streptomyces venezuelae. CmlA houses the diiron cluster in a metallo-β-lactamase protein fold instead of the 4-helix bundle fold of nearly every other diiron monooxygenase. CmlA couples O2 activation and substrate hydroxylation via a structural change caused by formation of the l-PAPA-loaded CmlP:CmlA complex. The other new diiron family is typified by two enzymes, AurF and CmlI, which catalyze conversion of aryl-amine substrates to aryl-nitro products with incorporation of oxygen from O2. AurF from Streptomyces thioluteus catalyzes the formation of p-nitrobenzoate from p-aminobenzoate as a precursor to the biostatic compound aureothin, whereas CmlI from S. venezuelae catalyzes the ultimate aryl-amine to aryl-nitro step in chloramphenicol biosynthesis. Both enzymes stabilize a novel type of peroxo-intermediate as the reactive species. The rare 6-electron N-oxygenation reactions of CmlI and AurF involve two progressively oxidized pathway intermediates. The enzymes optimize efficiency by utilizing one of the reaction pathway intermediates as an in situ reductant for the diiron cluster, while simultaneously generating the next pathway intermediate. For CmlI, this reduction allows mid-pathway regeneration of the peroxo intermediate required to complete the biosynthesis. CmlI ensures specificity by carrying out the multistep aryl-amine oxygenation without dissociating intermediate products.

Indexed as

Bacterial ProteinsBiological ProductsBiosynthetic PathwaysChloramphenicolCrystallography, X-RayKineticsMixed Function OxygenasesOxygenOxygenasesPeptide SynthasesProtein Conformation4-aminobenzoate N-oxygenaseBacterial ProteinsBiological ProductsChloramphenicolMixed Function Oxygenasesnon-ribosomal peptide synthaseOxygenOxygenasesPeptide Synthases

Identifiers

PMID29552683
PMCPMC6051903
OpenAlexW2792584246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.